These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33661287)

  • 1. Primary Care and Mental Health Prescribers, Key Clinical Leaders, and Clinical Pharmacist Specialists' Perspectives on Opioids and Benzodiazepines.
    Hawkins EJ; Lott AM; Danner AN; Malte CA; Hagedorn HJ; Berger D; Donovan LM; Sayre GG; Mariano AJ; Saxon AJ
    Pain Med; 2021 Jul; 22(7):1559-1569. PubMed ID: 33661287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary-Care Prescribers' Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults.
    Niznik JD; Ferreri SP; Armistead LT; Kelley CJ; Schlusser C; Hughes T; Henage CB; Busby-Whitehead J; Roberts E
    Drugs Aging; 2022 Sep; 39(9):739-748. PubMed ID: 35896779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of Primary Care and Mental Health Prescribers' Perspectives on Reducing Opioid and Benzodiazepine Co-Prescribing Among Veterans.
    Hawkins EJ; Malte CA; Hagedorn HJ; Berger D; Frank A; Lott A; Achtmeyer CE; Mariano AJ; Saxon AJ
    Pain Med; 2017 Mar; 18(3):454-467. PubMed ID: 27558857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: A rapid review.
    Niznik JD; Collins BJ; Armistead LT; Larson CK; Kelley CJ; Hughes TD; Sanders KA; Carlson R; Ferreri SP
    Res Social Adm Pharm; 2022 Jun; 18(6):2913-2921. PubMed ID: 34281786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial.
    Niznik J; Ferreri SP; Armistead L; Urick B; Vest MH; Zhao L; Hughes T; McBride JM; Busby-Whitehead J
    Trials; 2022 Apr; 23(1):256. PubMed ID: 35379307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors.
    Williams S; Louissaint J; Nikirk S; Bajaj JS; Tapper EB
    United European Gastroenterol J; 2021 Mar; 9(2):193-202. PubMed ID: 33226300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.
    Keller MS; Carrascoza-Bolanos J; Breda K; Kim LY; Kennelty KA; Leang DW; Murry LT; Nuckols TK; Schnipper JL; Pevnick JM
    BMJ Open; 2023 Feb; 13(2):e066234. PubMed ID: 36813499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis.
    Langford AV; Gnjidic D; Lin CC; Bero L; Penm J; Blyth FM; Schneider CR
    BMJ Qual Saf; 2021 Feb; 30(2):133-140. PubMed ID: 32220937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Those Conversations in My Experience Don't Go Well": A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications.
    Kennedy LC; Binswanger IA; Mueller SR; Levy C; Matlock DD; Calcaterra SL; Koester S; Frank JW
    Pain Med; 2018 Nov; 19(11):2201-2211. PubMed ID: 29126138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' Perspectives on Tapering of Chronic Opioid Therapy: A Qualitative Study.
    Frank JW; Levy C; Matlock DD; Calcaterra SL; Mueller SR; Koester S; Binswanger IA
    Pain Med; 2016 Oct; 17(10):1838-1847. PubMed ID: 27207301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers, facilitators, and resources to opioid deprescribing in primary care: experiences of general practitioners in Australia.
    Hamilton M; Mathieson S; Gnjidic D; Jansen J; Weir K; Shaheed CA; Blyth F; Lin CC
    Pain; 2022 Apr; 163(4):e518-e526. PubMed ID: 33990105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and Enablers of Deprescribing: A General Practitioner Perspective.
    Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
    PLoS One; 2016; 11(4):e0151066. PubMed ID: 27093289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider beliefs about the ideal design of an opioid deprescribing and substitution intervention for older adults.
    Margraf AM; Davoodi NM; Chen K; Shield RR; McAuliffe LM; Collins CM; Zullo AR
    Am J Health Syst Pharm; 2023 Jan; 80(2):53-60. PubMed ID: 36205419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Pharmacist Email Alerts on Concurrent Prescribing of Opioids and Benzodiazepines by Prescribers and Primary Care Managers: A Randomized Clinical Trial.
    Sacarny A; Safran E; Steffel M; Dunham JR; Abili OD; Mohajeri L; Oh PT; Sim A; Brutcher RE; Spevak C
    JAMA Health Forum; 2022 Sep; 3(9):e223378. PubMed ID: 36218952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the role of clinical pharmacists on interdisciplinary primary care teams for chronic pain and opioid management.
    Giannitrapani KF; Glassman PA; Vang D; McKelvey JC; Thomas Day R; Dobscha SK; Lorenz KA
    BMC Fam Pract; 2018 Jul; 19(1):107. PubMed ID: 29970008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives of health professionals towards deprescribing practice in Asian nursing homes: a qualitative interview study.
    Kua CH; Mak VS; Lee SWH
    BMJ Open; 2019 Oct; 9(10):e030106. PubMed ID: 31604786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid deprescribing: Qualitative perspectives from those with chronic non-cancer pain.
    Hamilton M; Gnjidic D; Christine Lin CW; Jansen J; Weir KR; Shaheed CA; Blyth F; Mathieson S
    Res Social Adm Pharm; 2022 Dec; 18(12):4083-4091. PubMed ID: 35963766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Survey of Prescribers' Attitudes, Knowledge, Comfort, and Fear of Consequences Related to an Opioid Overdose Education and Naloxone Distribution Program.
    Peckham AM; Niculete ME; Steinberg H; Boggs DL
    J Public Health Manag Pract; 2018; 24(4):310-317. PubMed ID: 29084123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.
    Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF
    J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
    BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.